Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii.
about
Intestinal microbiota in human health and disease: the impact of probioticsSaccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a reviewEnvironmental Enteric Dysfunction Is Associated With Poor Linear Growth and Can Be Identified by Host Fecal mRNAsMetagenomic insights into tetracycline effects on microbial community and antibiotic resistance of mouse gut.Application of sequence-dependent electrophoresis fingerprinting in exploring biodiversity and population dynamics of human intestinal microbiota: what can be revealed?Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study.Impact of a synbiotic food on the gut microbial ecology and metabolic profilesEffects of Bacillus subtilis KN-42 on Growth Performance, Diarrhea and Faecal Bacterial Flora of Weaned PigletsComparison of DNA extraction kits for PCR-DGGE analysis of human intestinal microbial communities from fecal specimensDuodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization.The role of microbiota in hepatic encephalopathyUse of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review.Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease.Intake of whole apples or clear apple juice has contrasting effects on plasma lipids in healthy volunteers.Reciprocal interaction between intestinal microbiota and mucosal lymphocyte in cynomolgus monkeys after alemtuzumab treatment.Dynamics of fecal microbial communities in children with diarrhea of unknown etiology and genomic analysis of associated Streptococcus lutetiensis.Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal ProbiomeDietary Enterococcus faecalis LAB31 improves growth performance, reduces diarrhea, and increases fecal Lactobacillus number of weaned piglets.Caecal fermentation, putrefaction and microbiotas in rats fed milk casein, soy protein or fish meal.In vitro culture conditions for maintaining a complex population of human gastrointestinal tract microbiota.Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathyNew approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.Linkage of gut microbiome with cognition in hepatic encephalopathyDynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR.Discerning the role of Bacteroides fragilis in celiac disease pathogenesis.Impact of antimicrobial residues on gut communities: are the new regulations effective?Efforts to emulate human milk oligosaccharides.Importance of gut microbiota in health and diseases of new born infants.Probiotic bacteria influence the composition and function of the intestinal microbiota.Dynamic In Vitro Models of the Human Gastrointestinal Tract as Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut Microbiota.The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial.Propionate as a health-promoting microbial metabolite in the human gut.The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese IndividualsMilk fermentation products of L. helveticus R389 activate calcineurin as a signal to promote gut mucosal immunity.Coculture fermentations of Bifidobacterium species and Bacteroides thetaiotaomicron reveal a mechanistic insight into the prebiotic effect of inulin-type fructans.Bifidogenic effect and stimulation of short chain fatty acid production in human faecal slurry cultures by oligosaccharides derived from lactose and lactulose.Prebiotics and synbiotics in ulcerative colitis.Consumption of fructo-oligosaccharide reduces 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice.Diversity responses of rumen microbial communities to Fusarium-contaminated feed, evaluated with rumen simulating technology.
P2860
Q24628739-10E916E9-391C-4C02-A40E-196B252E14CDQ26796416-F70EFD59-CA03-42AE-B6C9-F2D920C25D13Q30826823-E049CD3A-43BA-43D2-8F41-2929CBC1893CQ30999668-F5893E03-EBD9-465C-B743-54C8568AC694Q33416742-7D2AD7D3-4942-4692-9898-BAC6477A2A2DQ33420665-4752D4BD-6D83-4122-8024-A5EF021CD30CQ33444591-03DBDE96-0E37-470F-BB73-AADFA4C55946Q33522471-7EAE03EB-F353-4D45-A63F-01AB75F6005AQ33945478-BA1535EA-0373-49BD-B8E7-C14A83EA465EQ33981499-4B9D2977-071B-4134-A630-51E8F964C9B8Q34039831-3F2C5264-9EAC-4DF1-BB26-C101A153EBC9Q34129402-D067FE89-F937-4348-BD25-B8969F6E1374Q34144918-F87256DF-501E-4462-88EA-B4C2F8AAE538Q34243614-6CABF289-343F-45D6-AEA3-74143C906BCCQ34319853-ACA8B0D3-493E-4E41-BD99-7AC3CA23DC31Q34596752-EA6D2096-2BD2-43B0-BAE8-C696524344D6Q34778148-AA0E16B2-B8A5-469F-9D94-1F6E27F1189BQ34881370-294F01F8-6E71-4442-9757-8DECEB1BCF7BQ35009219-6075BCA8-9D4E-42F6-A7F4-E70866F90186Q35013878-436ECE4E-1A43-4DB2-9311-7ADF8D374CC7Q35138070-F39BDC9B-3016-4039-B881-EE2D8F9DDA7AQ35589590-F381B9B5-E8FE-46FE-93E1-3199944A274CQ35812927-711828FC-0451-46B2-96CB-324DC448DF82Q35939338-45A89D5C-14E9-49BF-B098-7E457C3EE08BQ36136734-782A6B45-DC4F-411E-8223-DE736620A314Q36186148-16640B10-E469-4F12-9AC6-47C6722AC453Q36797303-B8516968-BEB5-44EF-8B21-A5BFBB9875D2Q36965041-872B8975-A54D-4A1E-BB5E-931F7DBD2905Q37001049-31560048-A6AB-487E-999B-C5D5DDE9E51EQ37111218-CAF5FA2D-F261-465F-A1AE-6E92BCA41D5BQ37255990-3082C7CA-948A-4883-910A-B7A53E8BF062Q37291959-94855A6C-0B32-485C-830B-FC6BAD79A671Q37869183-F477CE2C-CFF3-4456-A013-7FCFBB7642B1Q38645113-6C344091-8C07-4573-8768-0B7411466646Q41782959-8E0A2DE5-DF37-4E35-AFA0-59CC477534BDQ41817818-739CBFE8-9973-4B05-A0A9-B4F6DA516F35Q46007324-2A526AB9-2B11-42EF-8351-8F15772A97A6Q46448965-F5F7C4AA-26A6-4314-A4DE-2D4417EA1F40Q46806246-60D2364E-95F9-4752-8A86-3400FF28A7DEQ46821636-E748263B-53B7-4BF0-961F-3612F39997EC
P2860
Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular monitoring of the fe ...... e and Saccharomyces boulardii.
@ast
Molecular monitoring of the fe ...... e and Saccharomyces boulardii.
@en
type
label
Molecular monitoring of the fe ...... e and Saccharomyces boulardii.
@ast
Molecular monitoring of the fe ...... e and Saccharomyces boulardii.
@en
prefLabel
Molecular monitoring of the fe ...... e and Saccharomyces boulardii.
@ast
Molecular monitoring of the fe ...... e and Saccharomyces boulardii.
@en
P2093
P2860
P356
P1476
Molecular monitoring of the fe ...... e and Saccharomyces boulardii.
@en
P2093
Evie De Brandt
Jean Swings
Kristin Verbeke
Tom Vanhoutte
P2860
P304
P356
10.1128/AEM.00233-06
P407
P577
2006-09-01T00:00:00Z